These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 24967961
21. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Lue LF, Yan SD, Stern DM, Walker DG. Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028 [Abstract] [Full Text] [Related]
22. Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity. Song J, Choi SM, Whitcomb DJ, Kim BC. Cell Death Dis; 2017 Oct 12; 8(10):e3102. PubMed ID: 29022894 [Abstract] [Full Text] [Related]
23. Aβ1-42 induces cell damage via RAGE-dependent endoplasmic reticulum stress in bEnd.3 cells. Chen W, Chan Y, Wan W, Li Y, Zhang C. Exp Cell Res; 2018 Jan 01; 362(1):83-89. PubMed ID: 29154819 [Abstract] [Full Text] [Related]
24. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models. Chai AB, Hartz AMS, Gao X, Yang A, Callaghan R, Gelissen IC. Int J Mol Sci; 2020 Dec 29; 22(1):. PubMed ID: 33383667 [Abstract] [Full Text] [Related]
25. Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model. Hanafy AS, Lamprecht A, Dietrich D. Fluids Barriers CNS; 2023 Nov 22; 20(1):85. PubMed ID: 37993886 [Abstract] [Full Text] [Related]
26. Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid β accumulation after Porphyromonas gingivalis infection. Zeng F, Liu Y, Huang W, Qing H, Kadowaki T, Kashiwazaki H, Ni J, Wu Z. J Neurochem; 2021 Aug 22; 158(3):724-736. PubMed ID: 32441775 [Abstract] [Full Text] [Related]
27. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. Xiong H, Callaghan D, Jones A, Bai J, Rasquinha I, Smith C, Pei K, Walker D, Lue LF, Stanimirovic D, Zhang W. J Neurosci; 2009 Apr 29; 29(17):5463-75. PubMed ID: 19403814 [Abstract] [Full Text] [Related]
28. Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. Hartz AM, Zhong Y, Wolf A, LeVine H, Miller DS, Bauer B. J Neurosci; 2016 Feb 10; 36(6):1930-41. PubMed ID: 26865616 [Abstract] [Full Text] [Related]
29. Aβ1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation. Guglielmotto M, Monteleone D, Boido M, Piras A, Giliberto L, Borghi R, Vercelli A, Fornaro M, Tabaton M, Tamagno E. Aging Cell; 2012 Oct 10; 11(5):834-44. PubMed ID: 22726800 [Abstract] [Full Text] [Related]
30. Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, Donahue JE, Johanson CE. J Neuropathol Exp Neurol; 2010 Oct 10; 69(10):1034-43. PubMed ID: 20838242 [Abstract] [Full Text] [Related]
31. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease. Wang CY, Xie JW, Xu Y, Wang T, Cai JH, Wang X, Zhao BL, An L, Wang ZY. Antioxid Redox Signal; 2013 Dec 10; 19(17):2024-39. PubMed ID: 23541064 [Abstract] [Full Text] [Related]
32. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Deane R, Zlokovic BV. Curr Alzheimer Res; 2007 Apr 10; 4(2):191-7. PubMed ID: 17430246 [Abstract] [Full Text] [Related]
33. beta-Amyloid efflux mediated by p-glycoprotein. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB. J Neurochem; 2001 Feb 10; 76(4):1121-8. PubMed ID: 11181832 [Abstract] [Full Text] [Related]
34. Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model. Fan X, Chai L, Zhang H, Wang Y, Zhang B, Gao X. Int J Mol Sci; 2015 Nov 18; 16(11):27576-88. PubMed ID: 26593909 [Abstract] [Full Text] [Related]
35. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. Candela P, Gosselet F, Saint-Pol J, Sevin E, Boucau MC, Boulanger E, Cecchelli R, Fenart L. J Alzheimers Dis; 2010 Nov 18; 22(3):849-59. PubMed ID: 20858979 [Abstract] [Full Text] [Related]
36. Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells. Askarova S, Yang X, Sheng W, Sun GY, Lee JC. Neuroscience; 2011 Dec 29; 199():375-85. PubMed ID: 21978883 [Abstract] [Full Text] [Related]
37. Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides. Bello I, Salerno M. Cell Stress Chaperones; 2015 May 29; 20(3):421-30. PubMed ID: 25591827 [Abstract] [Full Text] [Related]
38. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM. J Clin Invest; 2005 Nov 29; 115(11):3285-90. PubMed ID: 16239972 [Abstract] [Full Text] [Related]
39. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. Do TM, Noel-Hudson MS, Ribes S, Besengez C, Smirnova M, Cisternino S, Buyse M, Calon F, Chimini G, Chacun H, Scherrmann JM, Farinotti R, Bourasset F. J Alzheimers Dis; 2012 Nov 29; 30(1):155-66. PubMed ID: 22391220 [Abstract] [Full Text] [Related]
40. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder. Cai C, Dai X, Zhu Y, Lian M, Xiao F, Dong F, Zhang Q, Huang Y, Zheng Q. Appl Microbiol Biotechnol; 2016 Jan 29; 100(2):825-35. PubMed ID: 26496918 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]